Pan Ding
Pan Ding works at the masthead as an associate editor focused on research at the intersection of human health, ageing biology and data-rich omics studies. Her coverage is distinguished by a consistent interest in how large-scale molecular measurements and advanced analytical methods reveal mechanisms of disease and enable earlier, more precise detection.
Ageing biology and disease risk
A central thread in her portfolio is research that links biological ageing processes to concrete health outcomes. She handles work such as studies that use plasma proteomic signatures of cellular ageing to predict human disease risk, reflecting a focus on how measurable changes in proteins over time relate to morbidity and mortality in human cohorts. This places her editorial attention on translational ageing research, where basic mechanisms of cellular decline are connected to clinical endpoints. She gravitates toward manuscripts that quantify ageing trajectories rather than treating age as a simple demographic variable, highlighting work that can inform stratified prevention and intervention strategies.
Data-driven detection and prediction in medicine
Another distinguishing focus is on methods that use complex biomedical datasets to improve detection of disease. She oversees research articles such as the development of PanMETAI, a tabular foundation model that integrates NMR metabolomics, age, tumour markers and signalling proteins to detect pancreatic ductal adenocarcinoma with high accuracy, including at early stages. Her work in this area centres on studies that combine multiple data types and machine learning to increase sensitivity and specificity over conventional diagnostics. She gives particular attention to external validation, cohort diversity and performance on early-stage disease, favouring papers that demonstrate robustness across populations and clinical settings.
Multi-omics and molecular signatures in health
Across her health beat, Pan Ding’s portfolio regularly features multi-omics approaches that derive molecular signatures for disease states and progression. She works with manuscripts where clinical and biochemical parameters are integrated with proteomic or metabolomic data to generate predictive scores or risk models, emphasising the added value of combining modalities. This includes studies that show how protein profiles, small-molecule metabolites and conventional clinical markers can be fused in a single analytical framework to refine classification of patients and uncover new biological subgroups. Her editorial decisions in this area tend to favour work that links these signatures to clear clinical questions, such as early detection, prognosis, or treatment stratification.
Editorial role and scope at Nature Communications
At the masthead, she serves as an associate editor at Nature Communications and joined the journal in March 2026. In this role she manages peer review and selection of research submissions rather than day-to-day news reporting, shaping what is published in health-related sections of the journal. Her editorial scope covers human disease, ageing, and quantitative biomedical research, and she works with authors to refine how complex methodological advances are presented to a broad scientific readership. This combination of remit and subject matter means her influence is most visible in the type of high-impact health studies the journal carries, particularly those that rely on large datasets, advanced modelling and clinically relevant endpoints.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.